Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19

A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...
Orange County Business Journal

Irvine Biotech Firm Pursues Cancer Cure

The University of California, Irvine has licensed a new cancer-fighting immunotherapy to biotech firm GlyTR Therapeutics Inc.
The Lancet

Tumour-infiltrating lymphocyte therapy comes of age in the era of genetic engineering

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...